CDC: Alternative Medicine a Booming Business in U.S.

Share this content:
CDC: Alternative Medicine a Booming Business in U.S.
CDC: Alternative Medicine a Booming Business in U.S.

WEDNESDAY, June 22, 2016 (HealthDay News) -- Americans spent more than $30 billion out of pocket in 2012 on chiropractors and other complementary health practitioners, as well as supplements and other forms of alternative medicine, according to research published online June 22 in the U.S. Centers for Disease Control and Prevention's National Health Statistics Reports.

Expenditures in 2012 included the following: $14.7 billion out-of-pocket on visits to complementary practitioners such as chiropractors, yoga instructors, acupuncturists, or massage therapists -- nearly 30 percent of what people spent on traditional medical services; $12.8 billion on natural product supplements, which was about one-quarter of what people spent on prescription drugs; and $2.7 billion on books, CDs, videos, and other self-help materials related to complementary health.

According to the report, $28.3 billion was spent on adults, compared with just $1.9 billion for children. Study coauthor Richard Nahin, Ph.D., M.P.H., lead epidemiologist at the U.S. National Center for Complementary and Integrative Health, and his colleagues found that families making less than $25,000 a year spent, on average, $314 out-of-pocket on visits to complementary health practitioners in 2012, and an average $389 on natural supplements. Families earning incomes of $100,000 or more a year spent an average of $518 on complementary practitioners and an average of $377 on supplements.

Use of yoga has increased dramatically, while chiropractic care and massage therapy has tended to remain level. Use of natural supplements decreased slightly. Nahin told HealthDay that sales of fish oil supplements have increased four-fold since 2002 but sales of ginkgo biloba and echinacea decreased. Overall, spending on complementary medicine amounted to 9.2 percent of out-of-pocket health care expenditures and 1.1 percent of total health care expenditures in the United States, the researchers found.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »